Industry NewsRandox Laboratories and Biosytems International Announce Completion of Clinical Trial and Licensing for QuantiPlasma™ Antibodies for Early Lung Cancer Diagnostics
Product NewsRandox H-FABP, the Biomarker of Myocardial Ischemia that’s Detectable as early as 30 Minutes from Chest Pain Onset